Sphere No.49 (Aug 2019)

NEWS SPHERE #47 2019 06 ESDLIFE OWNS THE PODIUM The Digital Solutions Teamof ESD life took home nine outstanding awards this year at theMob-ex Awards (two gold, three silver and four bronze). eCommerce, creative experience and user experience were all among the winning categories for ESD life . Congratulations! Ports TERMINAL D OPENS FOR BUSINESS Hutchison Ports Thailand’s Terminal D in LaemChabang opened earlier this year with luminaries on hand including Dr Pailin Chuchottaworn, DeputyMinister of Transport. This high-tech project will increase LaemChabang’s container capacity by 40% and put Thailand at the cutting-edge of global ports technology. YANTIAN, BIGGER AND BETTER FOR CONTAINER SHIPS Hutchison Ports Yantian in Shenzhen, China has completed its expansion of berths 4, 5 and 6 and can now accommodate ships up to 6,600 TEUs. On 16 June 2019, Evergreen’s ship Ever Ethic arrived to inaugurate the expansion. SCHOOL IS IN! THANKS TO HUTCHISON PORTS The Ensenada International Terminal (EIT)-sponsored school in Ensenada, Mexico was visited by staff from the terminal with support for window replacements, outdoor furniture and school supplies. The students at Juan Escutia Primary School were thrilled with this assistance in helping them continue their studies! LEADING SHIP-TO-SHIP TRANSFER The world’s largest ship-to-ship transfer specialist, KA Petra, is collaborating withHutchison Ports to create the world’s largest ship-to-ship hub in Johor Bahru, Malaysia. Dignitaries presiding over the agreement signing ceremony included Yang Amat Berhormat Tun DrMahathir binMohamad, PrimeMinister of Malaysia, and Yang Berhormat Tuan Anthony Loke, Minister of Transport of Malaysia. Vive le Québec – avec Hutchison Ports! Hutchison Ports is joining with the Québec Port Authority and Canadian National Railway to develop a C$775 million new container terminal. Officials commended Hutchison Ports as “a world-class operator, with customer-focused experience which shares our business vision regarding supply chain efficiency, innovation, safety and environmental concern”. This is the ports group’s first project in Canada. OTHERS CHI-MED CLEARS AMAJOR MILESTONE FOR NOVEL CANCER DRUG The China Phase III registration trial of surufatinib, a new drug for fighting non- pancreatic neuroendocrine tumours, met its primary end point one year ahead of schedule. Chi-Med is preparing for the New Drug Application to be submitted in late 2019. Surufatinib treats cancer by cutting off the growth of blood vessels that support the growth of tumours. It also stimulates the body’s immune system to go after cancer cells.